Docetaxel
Showing 3151 - 3166 of 3,166
NSCLC Trial in United States (calcitriol + docetaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- calcitriol + docetaxel
-
Berkeley, California
- +10 more
May 3, 2007
NSCLC Trial in New York (Docetaxel, Jin Fu Kang)
Completed
- Non-Small Cell Lung Cancer
- Docetaxel
- Jin Fu Kang
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jan 25, 2007
NSCLC Trial in Sesto Fiorentino (Gemcitabine, docetaxel, cisplatin)
Completed
- Carcinoma, Non-Small-Cell Lung
- Gemcitabine
- +2 more
-
Sesto Fiorentino, Florence, ItalyFor additional information regarding investigative sites for thi
Jan 24, 2007
Prostate Cancer Trial in Villejuif (docetaxel and samarium)
Terminated
- Prostate Cancer
- docetaxel and samarium
-
Villejuif, FranceInstitut Gustave Roussy
Sep 7, 2006
Prostate Cancer Trial in Villejuif (docetaxel, laparoscopic radical prostatectomy)
Suspended
- Prostate Cancer
- docetaxel
- laparoscopic radical prostatectomy
-
Villejuif, FranceInstitut Gustave Roussy
Sep 7, 2006
Platinum Sensitive Relapsed Ovarian Cancer Trial in Saskatoon (Weekly Taxotere with weekly carboplatin)
Terminated
- Platinum Sensitive Relapsed Ovarian Cancer
- Weekly Taxotere with weekly carboplatin
-
Saskatoon, Saskatchewan, CanadaSaskatoon Cancer Center
Apr 20, 2007
Androgen Independent Prostate Cancer (AIPC), Non Small Cell Lung Cancer (NSCLC) Trial in Canada, United States (DN-101
Unknown status
- Androgen Independent Prostate Cancer (AIPC)
- Non Small Cell Lung Cancer (NSCLC)
- DN-101 (calcitriol) - Drug
-
Berkeley, California
- +12 more
May 30, 2006
Myelodysplastic Syndrome Trial in United States (DN-101 (calcitriol))
Unknown status
- Myelodysplastic Syndrome
- DN-101 (calcitriol)
-
Hoover, Alabama
- +9 more
Oct 31, 2006
Prostate Cancer Trial in Dallas (CG7870)
Terminated
- Prostate Cancer
- CG7870
-
Dallas, TexasMary Crowley Medical Research Center
Jan 31, 2006
Lung Cancer Trial (Patients were randomized to receive either docetaxel 60 mg/m2 on day 1 or vinorelbine 25 mg/m2 on days 1and
Completed
- Lung Cancer
- Patients were randomized to receive either docetaxel 60 mg/m2 on day 1 or vinorelbine 25 mg/m2 on days 1and 8, repeated every 21 days over four cycles.
- (no location specified)
Jan 5, 2006
Metastatic Breast Cancer Trial in Forli (Liposomal Doxorubicin (Myocet), Docetaxel and Trastuzumab)
Unknown status
- Metastatic Breast Cancer
- Liposomal Doxorubicin (Myocet), Docetaxel and Trastuzumab
-
Forli, ItalyOspedale Pietrantoni
Nov 7, 2005
NSCLC Trial in India, United Kingdom, United States (Pivanex, Docetaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- Pivanex
- Docetaxel
-
La Verne, California
- +7 more
Aug 26, 2005
Node Positive Breast Cancer Trial (6 TEC q 3 weeks, 4 EC q 2 weeks followed by 4 TXT q 2 weeks, 4 TXT q 2 weeks followed by 4 EC
Completed
- Node Positive Breast Cancer
- 6 TEC q 3 weeks
- +2 more
- (no location specified)
Sep 12, 2005
Advanced NSCLC, Other Solid Tumors Trial (VELCADE TM (bortezomib) for Injection, or PS-341)
Terminated
- Advanced Non-Small Cell Lung Cancer
- Other Solid Tumors
- VELCADE TM (bortezomib) for Injection, or PS-341
- (no location specified)
Jun 23, 2005